Tuesday, April 28, 2026

Did Coupang Influence Trump’s Tariff Decisions? Unpacking the Controversy

Prime Minister Kim Min-seok clarifies misunderstandings about U.S. tariff pressures linked to Coupang's lobbying efforts, emphasizing communication.

Golf, Politics, and Power: Lobby Teases a Thrilling Look at Lobbying in Korea

The film *Lobby* explores the high-stakes world of lobbying through Chang Wook, a startup CEO, aiming for a $3 billion contract.

Korean Automotive Industry Welcomes New U.S. Investment Law: What It Means for EV and Hybrid Growth in 2026

South Korea's automotive industry welcomes a new law easing U.S. tariff concerns, boosting local production and investment in future mobility.

Tag: John Rim

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Top News

- Our Sponsors Ad -

Follow us